Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic cancer models
RNA-seq (gene expression) · mouse · 10 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 10 samples: 3 × Panc02 cell, untreat vs 3 × Panc02 cell, treated with TNFa vs 2 × Panc02 cell, sgCadGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting plasticity in the pyrimidine synthesis pathway potentiates macrophage-mediated phagocytosis in pancreatic cancer modelsThe Journal of clinical investigation · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE262721_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1093055 and SRA study SRP498507. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 8 samples.
How we read this: 3 replicated groups read from 10 sample titles; they account for 8 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8174486 Panc02 cell, sgCad-1, co-cultured with BMDMs
- GSM8174487 Panc02 cell, sgCad-2, co-cultured with BMDMs
- GSM8174488 Panc02 cell, sgCad-1 Panc02 cell, sgCad
- GSM8174489 Panc02 cell, sgCad-2 Panc02 cell, sgCad
- GSM8174490 Panc02 cell, untreat-1 Panc02 cell, untreat
- GSM8174491 Panc02 cell, untreat-2 Panc02 cell, untreat
- GSM8174492 Panc02 cell, untreat-3 Panc02 cell, untreat
- GSM8174493 Panc02 cell, treated with TNFa-1 Panc02 cell, treated wi…
- GSM8174494 Panc02 cell, treated with TNFa-2 Panc02 cell, treated wi…
- GSM8174495 Panc02 cell, treated with TNFa-3 Panc02 cell, treated wi…
- GSE327618 Targeting microglial phosphatidylethanolamine synthesis pathway promotes GABARAP-associated phagocytosis and A clearance in Alzheimer's disease 9 samples shares phagocytosis, targeting, synthesis
- GSE287625 Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity 18 samples shares plasticity, pancreatic
- GSE202300 KDM6 Histone Demethylases Tune Pancreatic Cancer Plasticity 17 samples shares plasticity, pancreatic
- GSE253927 ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma [RNA-seq isoAC] 12 samples shares plasticity, pancreatic
- GSE297058 Hereditary Chronic Pancreatitis Induced Plasticity Cooperates with Mutant Kras in Early Pancreatic Carcinogenesis 128 samples shares plasticity, pancreatic
- GSE308575 NSD2 targeting reverses lineage plasticity and drug resistance in advanced prostate cancer [Cut&Tag] 58 samples shares plasticity, targeting
- GSE87472 The EMT-activator Zeb1 is crucial for cellular plasticity and drives metastasis in pancreatic cancer 36 samples shares plasticity, pancreatic
- GSE252839 Nuclear Factor NFAT5 Governs Cellular Plasticity-Induced KRAS-Targeted Therapy Resistance in Pancreatic Cancer 24 samples shares plasticity, pancreatic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.